^
Association details:
Evidence:
Evidence Level:
Sensitive: A1 - Approval
Source:
Published date:
10/20/2020
Excerpt:
TRISENOX is an arsenical indicated...For induction of remission and consolidation in patients with APL who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression.
Evidence Level:
Sensitive: A1 - Approval
Source:
Published date:
10/20/2020
Excerpt:
TRISENOX is an arsenical indicated:...In combination with tretinoin for treatment of adults with newly-diagnosed low-risk acute promyelocytic leukemia (APL) whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression.
Secondary therapy:
tretinoin
Evidence Level:
Sensitive: B - Late Trials
Title:

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

Published date:
07/11/2013
Excerpt:
Eligible patients were 18 to 71 years of age with newly diagnosed APL...demonstration of the t(15;17) translocation by means of conventional karyotyping or fluorescence in situ hybridization (FISH)...Patients were randomly assigned to receive ATRA plus arsenic trioxide...Hematologic complete remission was achieved in all 77 patients in the ATRA–arsenic trioxide group (100%) and in 75 of the 79 patients in the ATRA–chemotherapy group (95%) (P=0.12).
DOI:
10.1056/NEJMoa1300874
Trial ID:
Evidence Level:
Sensitive: C2 – Inclusion Criteria
New
Go to data
Title:

Phase III Trial in Acute Promyelocytic Leukemia Patients

Excerpt:
...- Serum creatinine ≤ 3.0 mg/dL (≤ 260 µmol/L) The confirmation of diagnosis at genetic level (microspeckled PML nuclear distribution by PGM3 monoclonal antibody and/or PML/RARa fusion by RT-PCR and/or demonstration of t(15;17) by karyotyping) will be mandatory for patient eligibility....
Trial ID:
Evidence Level:
Sensitive: C2 – Inclusion Criteria
New
Title:

Retrospective study of realgar-indigo naturalis formula in the treatment of patients with relapsed and arsenic trioxide-resistant acute promyelocytic leukemia

Excerpt:
...Demonstration of PML-RARα fusion transcripts by RT-PCR or cytogenetic demonstration of t(15;17)(q22;q12); 3. ...